LENZ Therapeutics (LENZ) Revenue & Revenue Breakdown
LENZ Therapeutics Revenue Highlights
0
Latest Revenue (Q)
$5.00M
LENZ Therapeutics Revenue by Period
LENZ Therapeutics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | - | -100.00% |
| 2022-12-31 | $15.00M | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2019-12-31 | - | - |
LENZ Therapeutics generated - in revenue during NA 2023, up -100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
LENZ Therapeutics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-06-30 | $5.00M | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $66.00K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | 100.00% |
| 2020-09-30 | - | 100.00% |
| 2020-06-30 | - | 100.00% |
| 2020-03-31 | - | - |
LENZ Therapeutics generated $5.00M in revenue during Q2 2025, up 100.00% compared to the previous quarter, and up Infinity% compared to the same period a year ago.
LENZ Therapeutics Revenue Breakdown
LENZ Therapeutics Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Sep 25 | Jun 25 |
|---|---|---|
| License | $5.00M | - |
| Reportable Segment | - | $5.00M |
Latest
LENZ Therapeutics's latest quarterly revenue breakdown by segment (product or service), as of Sep 25: License (100.00%).
LENZ Therapeutics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MRVI | Maravai LifeSciences | $259.19M | $41.63M |
| SPRY | ARS Pharmaceuticals | $89.15M | $32.50M |
| GERN | Geron | $76.50M | $47.23M |
| NBTX | Nanobiotix | $30.06M | $30.06M |
| ABUS | Arbutus Biopharma | $6.17M | $529.00K |
| PRME | Prime Medicine | $2.98M | $1.23M |
| RZLT | Rezolute | - | - |
| LENZ | LENZ Therapeutics | - | $5.00M |
| SVRA | Savara | - | - |
| GHRS | GH Research | - | $80.00K |
| TYRA | Tyra Biosciences | - | - |